TrialBMC infectious diseases2021

Ivermectin to prevent hospitalizations in patients with COVID-19 (IVERCOR-COVID19) a randomized, double-blind, placebo-controlled trial.

Julio Vallejos et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.